LRP2 Protein (Megalin)

LRP2 Protein (Megalin)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LRP2 Protein (Megalin)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>LRP2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>LRP2 (Megalin)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=LRP2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">182 edges</a></td>
</tr>
</table>

Pathway Diagram

LRP2 Protein (Megalin)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LRP2 Protein (Megalin)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>LRP2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>LRP2 (Megalin)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=LRP2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">182 edges</a></td>
</tr>
</table>

Pathway Diagram

[LRP2](/proteins/lrp2), commonly called megalin, is a giant multiligand endocytic receptor of the LDL receptor family with high physiological relevance at epithelial interfaces, including the choroid plexus and brain barriers.[@may2002][@christensen2002] In neurodegeneration, megalin is important because it can influence macromolecule trafficking between blood, cerebrospinal fluid (CSF), and brain parenchyma, thereby shaping exposure to ligands involved in amyloid homeostasis, lipid transport, endocrine signaling, and inflammatory tone.[@krzyzanowska2011][@fujiyoshi2011]

Unlike single-target enzymes, LRP2 is a systems regulator: it controls uptake of many classes of ligands, and this broad cargo profile means disease effects are often indirect and context-dependent.[@may2002][@kur2012] Its relevance to disorders such as [Alzheimer's disease](/diseases/alzheimers-disease) and related proteinopathies is strongest at the level of barrier biology, CSF exchange, and clearance efficiency.[@krzyzanowska2011][@fujiyoshi2011]

Structural and Functional Biology

Recent structural studies have clarified LRP2 as a modular "molecular machine" for receptor-mediated endocytosis, with repeated ligand-binding modules that permit broad cargo recognition and efficient internalization cycles.[@elkhattouti2023][@elkhattouti2024]

Core functional features include:

Because LRP2 functions in tissues with high transport demand, small changes in receptor abundance or compartmental routing can produce measurable downstream effects on CSF composition and neuronal exposure to circulating signals.[@krzyzanowska2011][@dietrich2015]

Choroid Plexus, CSF Turnover, and Amyloid-Relevant Transport

At the blood-CSF barrier, transporter expression is dynamic across aging and disease states.[@krzyzanowska2011] Multiple studies indicate that receptor systems at this interface contribute to [amyloid-beta](/proteins/amyloid-beta) movement and clearance from CSF.[@fujiyoshi2011][@shibata2000] While [LRP1](/proteins/lrp1) has clearer direct experimental support in specific amyloid-beta transport assays, LRP2/megalin is repeatedly implicated as part of the broader clearance architecture and barrier response network.[@krzyzanowska2011][@dietrich2015][@shibata2000]

For translational framing:

• Barrier dysfunction can amplify proteotoxic stress by reducing effective clearance.
• Clearance pathways are distributed; no single receptor explains all variance.
• LRP2 likely contributes through ligand handling, receptor crosstalk, and epithelial metabolic state.

Glial and Brain-Resident Cell Context

Beyond epithelial surfaces, LRP2 expression/function has been examined in CNS-resident cells including [astrocytes](/entities/astrocytes) and [microglia](/cell-types/microglia-neuroinflammation).[@muresan2024] These data suggest that megalin may contribute to local ligand uptake programs that influence inflammatory signaling and metabolic support, although disease-stage and cell-state effects remain underdefined.

Additional brain-relevant work links LRP2 receptor systems to micronutrient and selenium-associated pathways through barrier transport networks, with potential implications for oxidative stress resilience and neuronal survival programs.[@burk2014]

Neurodegeneration-Relevant Evidence

Alzheimer's Disease

Evidence is strongest at the mechanistic level (barrier transport and clearance pathways) and weaker at direct intervention-level proof. CSF studies report altered soluble megalin in AD cohorts, consistent with barrier pathway disturbance, but causality and directionality are unresolved.[@dietrich2015]

Parkinsonian and Tauopathy Contexts

Direct human disease datasets are limited. However, because barrier and glymphatic/CSF exchange dysfunction are transdiagnostic features across neurodegenerative disorders, LRP2 is mechanistically relevant as a candidate modifier in [PSP](/diseases/progressive-supranuclear-palsy), [CBD](/diseases/corticobasal-degeneration), and [Parkinson's disease](/diseases/parkinsons-disease) models that emphasize clearance failure.[@krzyzanowska2011][@muresan2024]

Evidence Grading

• Mechanistic plausibility: moderate to high.
• Human causal evidence in neurodegeneration: limited.
• Best role: barrier-pathway stratification marker and combination-therapy context node.

Clinical and Experimental Translation

Near-term high-value directions:

These approaches are preferable to single-pathway attribution and better reflect the distributed nature of clearance biology in neurodegeneration.[@may2002][@krzyzanowska2011][@kur2012]

See Also

• [LRP1B Protein](/proteins/lrp1b)
• [ATAXIN1 Protein](/proteins/ataxin1-protein)
• [Endolysosomal Trafficking Defects](/mechanisms/endolysosomal-trafficking-defects)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [PSP](/diseases/progressive-supranuclear-palsy)

External Links

• [UniProt: lrp2](https://www.uniprot.org/)
• [PubMed: lrp2](https://pubmed.ncbi.nlm.nih.gov/?term=lrp2+neurodegeneration)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving LRP2 Protein (Megalin) discovered through SciDEX knowledge graph analysis: